GWM
EDIT icon

Gibbs Wealth Management’s Editas Medicine EDIT Stock Holding History

Gibbs Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.5K Hold
10,308
– – ﹤0.01% 432
2025
Q4 		$21.3K Hold
10,308
– – 0.01% 324
2025
Q3 		$35.8K Hold
10,308
– – 0.01% 328
2025
Q2 		$22.7K Sell
10,308
-30
-0.3% -$49 ﹤0.01% 367
2025
Q1 		$12K Sell
10,338
-25
-0.2% -$37 ﹤0.01% 307
2024
Q4 		$13.2K Hold
10,363
– – ﹤0.01% 285
2024
Q3 		$35.3K Buy
10,363
+30
+0.3% +$131 0.01% 256
2024
Q2 		$48.3K Buy
+10,333
New +$58.3K 0.02% 229

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gibbs Wealth Management's EDIT Position: Q1 2026 in Review

Gibbs Wealth Management held its Editas Medicine (EDIT) position steady in Q1 2026 at 10,308 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

Gibbs Wealth Management first reported a position in EDIT in Q2 2024 and has held it in 8 quarters since. The position peaked at $48.3K in Q2 2024. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Gibbs Wealth Management held 10,308 shares of Editas Medicine worth $25.5K as of Q1 2026.
  • Gibbs Wealth Management left its Editas Medicine share count unchanged in Q1 2026.
  • Editas Medicine made up ﹤0.01% of Gibbs Wealth Management's portfolio in Q1 2026, its #432 holding.
  • Gibbs Wealth Management first reported a position in Editas Medicine in Q2 2024 and has held it in 8 quarters since.
  • Gibbs Wealth Management's Editas Medicine position peaked at $48.3K in Q2 2024.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.